On July 30, 2019 Evelo Biosciences, Inc. (Nasdaq: EVLO) ("Evelo"), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects, reported that it will host a conference call and live webcast at 8:30 A.M. ET on Tuesday, August 6, 2019 to report its second quarter financial results and discuss recent business updates (Press release, Evelo Biosciences, JUL 30, 2019, View Source [SID1234538811]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the live conference call, please dial 1-866-795-3242 (domestic) or 1-409-937-8909 (international) and refer to conference ID 6380636. A live webcast of the event will also be available under "News and Events" in the Investors section of Evelo’s website at View Source The archived webcast will be available on Evelo’s website approximately two hours after the completion of the event and will be available for 30 days following the call.